Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 10/10/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–10/09/2026 Record Record Date Vuga Group Change Status Recency Days Research Attention Score Cyclophosphamide Followed by Intravenous and Intraperitoneal Infusion of Autologous T Cells Genetically Engineered to Secrete IL-12 and to Target the MUC16ecto Antigen in Patients With Recurrent MUC16ecto+ Solid Tumors 07/15/2015 INTERVENTIONAL not-comparable 4,105.75 0 Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer 07/20/2015 INTERVENTIONAL not-comparable 4,100.75 0 Eat, Move, Live Intervention in Reducing Chronic Disease Risk in Medically Vulnerable Communities 07/31/2015 INTERVENTIONAL not-comparable 4,089.75 0 Hypofractionated Regional Nodal Irradiation Clinical Trial for Women With Breast Cancer 08/04/2015 INTERVENTIONAL not-comparable 4,085.75 0 Breast Cancer 2-PREVENT Translational Center of Excellence (TCE) - Metastatic Markers of Recurrent Tumor Phenotype for Breast Cancer 08/20/2015 OBSERVATIONAL not-comparable 4,069.75 0 Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH 08/20/2015 INTERVENTIONAL not-comparable 4,069.75 0 Study of Chemotherapy-Induced Hair Changes and Alopecia, Skin Aging and Nail Changes in Women With Non-Metastatic Breast Cancer 08/20/2015 OBSERVATIONAL not-comparable 4,069.75 0 Neoadjuvant Endocrine Therapy Versus Chemotherapy in Premenopausal Patients With ER+ & HER2- Breast Cancer 08/28/2015 INTERVENTIONAL not-comparable 4,061.75 0 Preovulatory Uterine Flushing With Saline as a Treatment for Unexplained Infertility 09/03/2015 INTERVENTIONAL not-comparable 4,055.75 0 Acute and Long-term Cardiovascular Toxicity After Modern Radiotherapy for Breast Cancer 09/04/2015 OBSERVATIONAL not-comparable 4,054.75 0 Biomarker Guided Treatment in Gynaecological Cancer 09/07/2015 INTERVENTIONAL not-comparable 4,051.75 0 Treatments for Urogynaecological Problems and Patient Selfreports 09/15/2015 OBSERVATIONAL not-comparable 4,043.75 0 Fetoscopic Endoluminal Tracheal Occlusion in Severe Left Congenital Diaphragmatic Hernia 09/15/2015 INTERVENTIONAL not-comparable 4,043.75 0 Neoadjuvant Lenvatinib Combined With Letrozole in Hormone Receptor Positive Breast Cancer 09/29/2015 INTERVENTIONAL not-comparable 4,029.75 0 Effect of Brief-tele Support on Attendance at Physiotherapy Sessions 09/30/2015 INTERVENTIONAL not-comparable 4,028.75 0 Safety and Efficacy of Omission of Sentinel Node Biopsy in Patients With Estrogen-Positive Breast Cancer Over Age 65 10/01/2015 INTERVENTIONAL not-comparable 4,027.75 0 Muscle Loss and Fatigue as a Consequence of Radiotherapy 10/05/2015 OBSERVATIONAL not-comparable 4,023.75 0 PARP-inhibition and CTLA-4 Blockade in BRCA-deficient Ovarian Cancer 10/08/2015 INTERVENTIONAL not-comparable 4,020.75 0 Uterine Transplantation for the Treatment of Uterine Factor Infertility 10/09/2015 INTERVENTIONAL not-comparable 4,019.75 0 Neuromodulation as a Treatment for Chemotherapy-Induced Peripheral Neuropathy 10/12/2015 INTERVENTIONAL not-comparable 4,016.75 0 PIERS and BIS, sFIT:PIGF, Adrenomedullin 10/19/2015 OBSERVATIONAL not-comparable 4,009.75 0 Toronto Gestational Glucose Tolerance Cohort 10/21/2015 OBSERVATIONAL not-comparable 4,007.75 0 Investigating the Impact of Obesity on Pubertal Development in Girls 10/22/2015 OBSERVATIONAL not-comparable 4,006.75 0 Beauty from Within Community Screening Project 10/28/2015 OBSERVATIONAL not-comparable 4,000.75 0 Anisotropic Textile Braces for Adolescent Idiopathic Scoliosis 10/28/2015 INTERVENTIONAL not-comparable 4,000.75 0 Neoadjuvant Response-guided Treatment of Slowly Proliferating Hormone Receptor Positive Tumors 10/30/2015 INTERVENTIONAL not-comparable 3,998.75 0 Vasculitis Pregnancy Registry 11/02/2015 OBSERVATIONAL not-comparable 3,995.75 0 AMH as a Predictor of Infertility Risk in Children With Cancer (CHANCE) 11/03/2015 OBSERVATIONAL not-comparable 3,994.75 0 Triapine With Chemotherapy and Radiation Therapy in Treating Patients With IB2-IVA Cervical or Vaginal Cancer 11/04/2015 INTERVENTIONAL not-comparable 3,993.75 0 Gemcitabine Hydrochloride Alone or With M6620 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer 11/04/2015 INTERVENTIONAL not-comparable 3,993.75 0 Fetoscopic Endoluminal Tracheal Occlusion (FETO) for Congenital Diaphragm Hernia 11/04/2015 INTERVENTIONAL not-comparable 3,993.75 0 Peripheral Blood Stem Cell Transplantation for Hematologic Malignancies With Alpha Beta TCell and B Cell Depletion Using the CliniMACS Device 11/09/2015 INTERVENTIONAL not-comparable 3,988.75 0 Latent Structure of Multi-level Assessments and Predictors of Outcomes for Women in Recovery 11/10/2015 OBSERVATIONAL not-comparable 3,987.75 0 Palbociclib in Combination With Bicalutamide for the Treatment of AR(+) Metastatic Breast Cancer (MBC) 11/16/2015 INTERVENTIONAL not-comparable 3,981.75 0 [18F]FLT PET/CT in Rb+ Metastatic Breast Cancer 11/18/2015 INTERVENTIONAL not-comparable 3,979.75 0 Strawberry Candy Twists as an Alternative Screen for Gestational Diabetes: A Prospective Trial 11/20/2015 INTERVENTIONAL not-comparable 3,977.75 0 THE INFLUENCE OF COGNITIVE BEHAVIORAL THERAPY IN SEXUAL DYSFUNCTION FEMALE: Randomized Clinical Trial 11/24/2015 INTERVENTIONAL not-comparable 3,973.75 0 Tomosynthesis Mammographic Imaging Screening Trial 11/27/2015 INTERVENTIONAL not-comparable 3,970.75 0 Women Informed to Screen Depending on Measures of Risk (Wisdom Study) 12/03/2015 INTERVENTIONAL not-comparable 3,964.75 0 Adjuvant Trastuzumab, Pertuzumab Plus Docetaxel in the Treatment of Early HER2-positive Breast Cancer 12/09/2015 INTERVENTIONAL not-comparable 3,958.75 0 Carboplatin, Gemcitabine Hydrochloride, and Berzosertib in Treating Patients With Recurrent and Metastatic Ovarian, Primary Peritoneal, or Fallopian Tube Cancer 12/11/2015 INTERVENTIONAL not-comparable 3,956.75 0 Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT 12/22/2015 INTERVENTIONAL not-comparable 3,945.75 0 TA(E)C-GP Versus A(E)C-T for the High Risk TNBC Patients and Validation of the mRNA-lncRNA Signature 12/30/2015 INTERVENTIONAL not-comparable 3,937.75 0 Sentinel Lymph Node Biopsy Versus Pelvic Lymphadenectomy in Early-stage Cervical Cancer (PHENIX/CSEM 010) 12/30/2015 INTERVENTIONAL not-comparable 3,937.75 0 Lateral Episiotomy or Not in Vacuum Assisted Delivery in Non-parous Women 12/30/2015 INTERVENTIONAL not-comparable 3,937.75 0 Ovarian Tissue Cryopreservation in Children 01/05/2016 INTERVENTIONAL not-comparable 3,931.75 0 Pain Control in Breast Surgery: Analgesia, Opioid Consumption and Inflammatory Response Evaluation 01/06/2016 INTERVENTIONAL not-comparable 3,930.75 0 Improving Maternal and Child Health Through Prenatal Fatty Acid Supplementation 01/06/2016 INTERVENTIONAL not-comparable 3,930.75 0 Acupuncture or Metformin for Insulin Resistance in Women With PCOS 01/06/2016 INTERVENTIONAL not-comparable 3,930.75 0 Reprometabolic Syndrome Mediates Subfertility in Obesity 01/12/2016 INTERVENTIONAL not-comparable 3,924.75 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 10/10/2026 · upstream last modified 10/10/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Research Attention Score using the documented compute method. · methodology